Skip to main content
Category

News

Week One: “Medicare is Better Than Ever” Tour Rolled Into New York, Pennsylvania, Michigan, Wisconsin

Lieutenant Governor, HHS Regional Directors, State and City Officials Headlined “Medicare is Better Than Ever” Tour Events to Educate Seniors About Lower Drug Prices

On the first week of Protect Our Care’s 7,000-mile “Medicare is Better Than Ever” tour, the Medicare-A-Van made stops in four states to educate seniors across the nation about new benefits thanks to legislation signed into law last year by President Biden. As seniors begin to enroll in their 2024 Medicare plans, they could save thousands of dollars on their prescription drug costs, with even more savings down the road.

During each stop, local elected officials, health care advocates, and storytellers discussed how the Inflation Reduction Act will improve care and lower costs for American seniors. Protect Our Care also made headlines across the nation educating seniors on the new benefits under the Inflation Reduction Act, including free vaccines, $35 insulin caps, protections from outrageous price hikes, and lower drug costs thanks to Medicare negotiation. 

Next week, the tour continues in Virginia, North Carolina, and Georgia. Over three weeks, the Medicare-A-Van will travel to more than 10 states, make more than 25 stops, and travel over 7,000 miles.

Watch All Tour Stops Here

Syracuse, New York

State Senator John Mannion and Syracuse Common Council President Helen Hudson joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at Syracuse City Hall to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • Spectrum News CNY: Protect Our Care Medicare is Better Than Ever Van Tour Stops in Syracuse

Watch the event here.

New Windsor, New York

State Senator James Skoufis joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Marasco Senior Center in New Windsor to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • MidHudson News: Protect Our Care’s Medicare is Better Than Ever tour rolls into Orange County
  • News12 Westchester: Protect Our Care Medicare is Better Than Ever Van Tour Stops in Westchester

Watch the event here.

Westchester, New York

Westchester County Executive George Latimer and HHS Regional Director Dara Kass joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Theodore D. Young Community Center in White Plains to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

Watch the event here.

Scranton, Pennsylvania

Scranton Mayor Paige Cognetti joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at Sheeley’s Drug Store in Scranton to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Harrisburg, Pennsylvania

Lieutenant Governor Austin Davis joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Heinz-Menaker Senior Center in Harrisburg to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • WGAL (NBC): Medicare is Better Than Ever in Harrisburg
  • WMPT (FOX): Medicare is Better Than Ever in Harrisburg
  • PACast: Medicare is Better Than Ever Tour in Harrisburg
  • 21News (CBS): Medicare is Better Than Ever Tour Touts Savings for Seniors
  • WGAL (NBC): Event touts Medicare improvements that could help seniors save thousands on prescription drugs

Watch the event here.

Flint, Michigan

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Brennan Senior Center in Flint to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

Watch the event here.

Lansing, Michigan

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Michigan State Capitol in Lansing to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Coverage:

  • WLAJ (ABC): Medicare is Better Than Ever Tour Visits Lansing
  • WILX (NBC): Medicare Helpers Tour The Nation

Watch the event here.

Madison, Wisconsin

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Goodman Community Center in Madison to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Milwaukee, Wisconsin

HHS Regional Director Michael Cabonargi joined Protect Our Care’s “Medicare is Better Than Ever” tour and health care advocates at the Washington Park Senior Center in Milwaukee to highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act which will lower premiums and prescription drug costs. 

Watch the event here.

Additional “Medicare Autumn” Coverage

National

Maryland

  • WBFF: Medicare Open Enrollment Brings New Benefits and Savings for Millions of Seniors

Michigan

Oklahoma

  • KOKH: Seniors to Experience Relief in 2024: New Savings on Skyrocketing Prescription Drug Costs

Tennessee

  • WTVC: Seniors to Experience Prescription Drug Cost Relief in 2024

Utah

  • KUTV: New Benefits for Seniors During Open Enrollment

Wisconsin

GREED WATCH: AbbVie Announces Nearly $14 Billion In Q3 Revenue Report, Beating Estimates and Raising Future Growth Expectations

This morning, AbbVie announced it raked in over $13.9 billion in the third quarter of 2023 – $24 million more than expected – during their earnings report. While they make billions, Americans pay exorbitantly high prices for prescription drugs. AbbVie opposes the Biden administration reforms that lower prescription drug prices.

  • During the call, CEO Rick Gonzales bragged about the company’s strong growth platform: “I’m extremely pleased with our continued strong momentum and execution across our business. Our growth platform is substantially outperforming our expectations.”
  • AbbVie announced it is rewarding its shareholders with a 4.7 percent dividend increase, payable in February 2024.
  • Imbruvica, AbbVie’s blockbuster leukemia drug that was selected among the first ten drugs to have lower prices negotiated by Medicare, brought in more than $900 million this quarter.
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

GREED WATCH: Merck Announces Over One Billion More Revenue This Quarter Than Last Year

Merck announced it raked in $16 billion this quarter – a $1.04 billion increase over last year – during their earnings report. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Merck opposes the Biden administration reforms that lower prescription drug prices. 

  • During the call, CEO Rob Davis bragged about the company’s “We remain committed to our dividend and plan to increase it over time. Business development continues to be a high priority. Our track record demonstrates our ability to identify compelling science and technologies that have the potential… to rapidly progress the opportunities for the benefit of… our shareholders.”
  • Merck announced it is rewarding its shareholders with $338 million in stock buybacks over just this past quarter. 
  • Merck is suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

GREED WATCH: Bristol Myers Squibb Announces $11 Billion In Q3 Earnings Report

Bristol Myers Squibb announced it raked in $11 billion this quarter during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Bristol Myers Squibb opposes Biden administration reforms that lower prescription drug prices. 

  • Eliquis, Bristol Myers Squibb’s blockbuster blood clot drug that was selected among the first ten drugs to have lower prices negotiated by Medicare, brought in $2.7 billion this quarter – a 2 percent increase over last year. 
  • Bristol Myers Squibb CEO Giovanni Caforio bragged about “the diversification of our business, the breadth of our new product portfolio and the strength of our pipeline” while his company is simultaneously suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • In August, Bristol Myers Squibb announced it is rewarding its shareholders with $4 billion in stock buybacks, which they expect to complete by the end of 2023. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

Another Extreme MAGA Choice to Lead the House: Mike Johnson’s Health Care Record Makes Him An Abysmal Choice For Speaker

Washington, D.C. — With the House GOP in utter chaos after failing to elect a Speaker once again, Republicans have rallied behind Rep. Mike Johnson (R-LA). Just like Kevin McCarthy and Jim Jordan, Mike Johnson has a long history of fighting to raise health care costs and rip away critical protections from the American people.

Since taking office in 2017, Johnson has opposed the Affordable Care Act and has worked to rip away protections for 135 million Americans with pre-existing conditions. He’s supported cuts to Medicare and Social Security, threatening the health and well-being of our nation’s seniors, and he supports a nationwide abortion ban. Johnson has spent the last four years fighting legislation to lower drug costs in order to keep Big Pharma’s profits high. Under Rep. Johnson’s leadership, Republicans will undoubtedly double down on their war on health care and their radical agenda of opposing the Affordable Care Act, slashing Medicare and Medicaid, and hiking drug and health insurance costs.

In response, Protect Our Care Executive Director Brad Woodhouse issued the following statement: 

“Mike Johnson is completely out of step with the American people on health care. He voted to repeal the Affordable Care Act and rip away protections for 135 million Americans pre-existing conditions. He supports cuts to Medicare and Social Security, and has spent years fighting to keep prescription drug costs high for seniors. Now, he wants to repeal the Inflation Reduction Act and stop Medicare from negotiating lower drug prices. Johnson’s record is clear and, under his leadership, Republicans will undoubtedly continue their radical agenda of attacking people with pre-existing conditions, repealing the Affordable Care Act, slashing Medicare, and hiking drug and health insurance costs.” 

If Mike Johnson got his way:

  • Medicare would be banned from negotiating lower prices for prescription drugs
  • Insulin prices would not have been capped at $35/month for seniors
  • Seniors would have to pay more than $2,000 a year out-of-pocket for prescriptions.
  • Drug companies would be able to once again raise prices faster than the rate of inflation without penalty.
  • Health care coverage for about 23 million people would have been eliminated by 2026
  • People with pre-existing conditions could again be denied coverage or charged higher prices
  • …. and so much more.

THE DETAILS: Mike Johnson Voted For Higher Premiums And Prescription Drug Costs 

2021: Mike Johnson, And Every Republican In Congress, Voted Against The Inflation Reduction Act. Johnson joined every Republican in Congress in voting against the Inflation Reduction Act, which “requires the Centers for Medicare & Medicaid Services (CMS) to negotiate the prices of certain prescription drugs under Medicare beginning in 2026,” and “requires drug manufacturers to issue rebates to the CMS for brand-name drugs without generic equivalents under Medicare medical services that cost $100 or more per year per individual and for which prices increase faster than inflation.” [HR 5376, Roll Call Vote #420, 8/12/21

  • Johnson Has Ties To Drug Industry Special Interests. Johnson has significant ties to the pharmaceutical and drug manufacturing industry, having pocketed $7,500 from the industry during the 2022 midterm election cycle while running unopposed. Big drug companies fiercely lobbied against the Inflation Reduction Act, which included provisions allowing the Department of Health and Human Services to negotiate prescription drug prices for Medicare.

What The Inflation Reduction Act Means For America:

2021: Mike Johnson, And Every Republican In Congress, Voted Against the American Rescue Plan. Johnson joined every Republican in Congress in voting against the American Rescue Plan, which “provide[d] health insurance premium assistance for individuals who become eligible for, and elect to enroll in, the COBRA (Consolidated Omnibus Budget Reconciliation Act) continuation coverage program,” increased the rate of “the refundable tax credit for coverage under qualified health plan”, and “ma[de] individuals who received unemployment compensation in 2021 eligible for cost-sharing subsidies for health care expenses under qualified health insurance plans.” [HR 1319, Roll Call Vote #72, 3/10/21

 What The American Rescue Plan Meant For America:

  • Saved families an average of $2,400 a year on their health insurance premiums.
  • Ensured all Americans never pay more than 8.5 percent of their household incomes towards an ACA Marketplace premium.
  • Eliminated premiums for people earning up to 150 percent of the federal poverty level who buy their coverage on the ACA Marketplace.
  • Extended the premium tax credit to 3.1 million Americans.

 2019: Mike Johnson Voted Against HR3. Johnson joined all but two House Republicans in voting against the Elijah Cummings Lower Drug Costs Now Act (HR 3), which would have lowered the cost of prescription drug prices by “empowering the federal government to negotiate prices with pharmaceutical manufacturers.” HR 3 would have required the Department of Health and Human Services to negotiate maximum prices for insulin, new and existing single-source brand-name drugs without generics, the top drugs expensed through Medicare and Medicare Advantage, and would have set price ceilings at 120% of the average price in similar countries or 85% of the price for domestic manufacturers. [HR 3, Roll Call Vote #682, 12/12/19] 

What HR 3 Meant For America:

Mike Johnson Opposes The ACA And Its Protections For 1 in 2 Americans With Pre-Existing Conditions

Johnson Voted Against Legislation To Protect Patients With Pre-Existing Conditions. Johnson voted against the Protecting Americans With Pre-Existing Conditions Act of 2019, which would have ensured affordable, robust coverage for patients with pre-existing conditions and blocked future administrations from skirting Affordable Care Act coverage requirements. [HR 986, Roll Call Vote #196, 5/9/19]

2017: Mike Johnson Supported Trump’s Disastrous ACA Replacement. In 2017, Johnson cast a decisive vote in passing the frantic Republican attempt to repeal the Affordable Care Act and rip away health coverage and protections for pre-existing conditions for millions of Americans. Johnson railed against the ACA throughout 2017, claiming numerous times that “Obamacare failed.” [HR 1628, Roll Call Vote #256, 5/4/17

  • Former President Trump Successfully Pressured Johnson To Support His ACA Repeal Effort. Johnson, considered a “trusted member of Donald Trump’s inner circle” during his administration, faced intense pressure to support his bid to repeal the Affordable Care Act in 2017: “…the then freshman congressman’s first conversation with the president left Johnson shaken and unsure about his political future. […] conservatives like Johnson and members of the ultra right Freedom Caucus balked, despite Trump’s support. ‘It was haphazardly drawn,’ Johnson said. ‘The party wasn’t prepared to act that soon. I couldn’t vote for it.’ Trump called Johnson and dressed him down in a fierce one-sided conversation when he heard the freshman planned to buck the president. ‘I thought that might be the end of my career,’ Johnson said. ‘The conversation was pretty intense.’ […] ‘The last thing I ever imagined when I was elected was that I would have to say no to the president on his first major piece of legislation,’ said Johnson…”

What Did AHCA Mean for America?

  • Approximately 1 in 2 people in America with pre-existing conditions would have lost protections for coverage.
  • 23 million people would have lost coverage under this bill by 2026
  • The nonpartisan Congressional Budget Office found that the American Health Care Act would have raised premiums by 20 percent.
  • The negative economic impact of the American Health Care Act would have caused 1.8 million people to lose their jobs by 2022.

2017: Within Days Of Joining The House of Representatives, Mike Johnson Voted To Begin The Process of Repealing The Affordable Care Act. Just 10 days after being sworn into office, Johnson voted for SCR 3, a budget resolution that included a provision starting the process of repealing the Affordable Care Act. [SCR 3, Roll Call Vote #58, 1/13/17]

Mike Johnson Wants To Slash Medicare, Medicaid, and Social Security.

Mike Johnson Is A Cheerleader For The Push To Cut, Partially Privatize Medicare And Social Security. Johnson has long defended GOP plans to cut Medicare and Social Security. He served as chair of the hardline Republican Study Committee (RSC) from 2019 to 2021, and still serves on the committee. The RSC released a budget outlining plans to raise the Medicare eligibility age to 67 and raise premiums for many seniors while partially privatizing the program. In 2012, Johnson voted to raise the retirement age to 70 and supported a budget attempting to end Medicare and shift costs to seniors

2017: Mike Johnson Voted To Cut Medicare By $473 Billion. Johnson voted for the FY 2018 budget resolution, which included $473 billion in cuts to Medicare over 10 years. [H Con Res 71, Vote #557, 10/5/17

2017: Mike Johnson Voted To Slash $1.3 Trillion From Medicaid. Johnson voted for the FY 2018 budget resolution, which cut funding for non-Medicare health programs, most notably Medicaid, by 1.3 trillion, a 20 percent cut over the course of 10 years, increasing to a 29.3 percent cut by 2027. [H Con Res 71, Vote #557, 10/5/17

2017: Mike Johnson Voted For Trump’s AHCA, Which Cut $880 Billion From Medicaid. Johnson voted for AHCA, which included $880 billion in cuts to Medicaid. [HR 1628, Roll Call Vote #256, 5/4/17]

  • Vox Called AHCA A “Sneaky” Reversal Of The Medicaid Expansion. “Medicaid, a government program that simply compensates health care providers at stingy rates, is much cheaper than private insurance. So the ACA’s authors chose to expand it to cover all families with incomes below 138 percent of the poverty line, rather than shelling out the money it would have cost to have the government pay for them to buy private insurance. The AHCA reverses this expansion. But to avoid the criticism that the law throws poor children off their health insurance, it reverses it in a somewhat sneaky way. Rather than taking Medicaid away from families who have it, it simply caps new enrollments in Medicaid so no new poor families can sign up. But the way this cap works, you can’t get back on Medicaid if you go off of it. So a poor family that gets a raise and becomes non-poor for a year will lose access to Medicaid permanently.” [Vox, 5/9/17]

U.S. Representative Moore to Discuss President Biden’s Latest Action to Lower Health Care Costs for Wisconsinites

***MEDIA ADVISORY FOR WEDNESDAY, OCTOBER 25 AT 2 PM CT // 3 PM ET***

While the Biden Administration Fights for Wisconsinites to Save Money on their Medications, Republicans Want to Raise Health Care Costs

Milwaukee, WI – On Wednesday, October 25 at 2:00 PM CT, 3:00 PM ET, U.S. Representative Gwen Moore (WI-04) and Milwaukee area health care advocates will join Protect Our Care Wisconsin to discuss how Medicare negotiations will lower prescription drug costs for Wisconsinites. The Biden administration announced the first 10 drugs that will have lower prices negotiated by Medicare under the Inflation Reduction Act, which was passed by Democrats last year. Earlier this month, all 10 companies entered into agreements with Medicare to kickstart the negotiation process to lower costs for seniors.  

Speakers will discuss what this means for Wisconsinites and how lowering the cost of healthcare and prescription drugs remain central to the Inflation Reduction Act’s popularity, and the importance of protecting these policies. 

This event comes as Republicans and drug companies are trying to derail health care policies that will bring down costs. Pharmaceutical companies are suing the federal government to protect their massive profits by halting the measure passed in the Inflation Reduction Act that empowers Medicare to negotiate drug prices while Republicans are attempting to repeal it. President Biden and Democrats in Congress are already working to expand these cost savings to more Americans, no matter what age they are or how they get their health insurance. If the GOP gets their way, they would throw millions of people off of Medicaid, keep drug costs high for seniors, and make health care coverage more expensive for families purchasing coverage on their own through the Affordable Care Act. 

WHO: U.S. Representative Gwen Moore & Milwaukee area health care advocates

WHAT: Virtual Press Conference

WHEN: Wednesday, October 25, 2:00 PM CT // 3:00 PM ET

WHERE: Register to join the Zoom event (Registration required)

###

GREED WATCH: Novartis Announces Over Half a Billion More in Q3 Sales Than Expected, Raising Yearly Guidance for the Third Consecutive Time

Novartis announced it raked in $11.78 billion this quarter – a $1.29 billion increase over last year – during their earnings report today. While they make billions, Americans pay exorbitantly high prices for prescription drugs. Novartis opposed the Biden administration reforms that lower prescription drug prices. 

  • During the call, CFO Harry Kirsch bragged about the company’s enormous growth saying, “core operating income is up 21 percent in quarter three… mainly driven by sales and savings from the ongoing [increasing] productivity.” 
  • Novartis announced that it has initiated the $15 billion stock buyback it announced in July 2023.
  • Novartis is suing the Biden administration to stop Medicare from negotiating lower drug prices for patients because it would endanger their massive profits. 
  • Drug companies charge Americans prices up to four times higher than prices in other countries, forcing patients to cut pills and skip doses to make ends meet. 
  • Over 80 percent of voters support giving Medicare the power to negotiate, making it the most popular provision in the Inflation Reduction Act. 

The Inflation Reduction Act brings down prescription drug costs for everyday Americans, especially seniors, by capping the price of insulin at $35 per month and providing free vaccines including shingles, giving Medicare the power to negotiate lower drug prices, and limiting the amount people have to pay each year for prescription drugs to $2,000 annually starting in 2025.  

Read more:

REPORT: Why Medicare Needs the Power to Negotiate for Lower Drug Costs: The Five Drugs That Tell the Story

FACT SHEET: Big Drug Companies Are in Court to Stop Medicare Negotiation and Protect Their Sky-High Profits

New Navigator Polling: Voters Rank Lowering Drug Prices as President Biden’s #1 Accomplishment

New Navigator polling reveals that voters view lowering drug costs as President Biden’s top accomplishment. The poll specifically named giving Medicare the power to negotiate lower drug costs and capping insulin costs for seniors at $35 per month, which were both included in the Inflation Reduction Act. These policies enjoy widespread, bipartisan support: according to Navigator, “lowering prescription drug prices by allowing Medicare to negotiate drug prices is President Biden’s most supported accomplishment, earning support from over three in four Americans (77 percent), including 71 percent of independents and 64 percent of Republicans.”

Protect Our Care recently launched the Medicare Autumn campaign to educate seniors about new benefits that will help them save on their prescription drugs thanks to President Biden and Democrats in Congress. Read more here.

In addition to finding broad support for President Biden’s action to lower drug costs, the poll also found that Americans are hearing most about this accomplishment when compared to other policy achievements. A majority of Americans (57%) have heard of his success in lowering drug prices through Medicare negotiation and capping insulin costs.

THIS WEEK: “Medicare is Better Than Ever” Tour Kicks Off With Stops in New York, Pennsylvania, Michigan, Wisconsin

Lieutenant Governor, HHS Regional Directors, State and City Officials Will Headline Events in Four States to Educate Seniors About Lower Vaccine and Drug Prices

Watch All Tour Stops Live Here.

Washington, D.C. — On the first week of the “Medicare is Better Than Ever” tour, Protect Our Care’s Medicare-A-Van will make stops in four states to educate seniors across the nation about new Medicare benefits thanks to legislation signed into law last year by President Biden. Headlining events are Pennsylvania Lieutenant Governor Austin Davis, HHS Regional Directors Dara Kass and Michael Cabonargi, New York State Senators John Mannion and James Skoufis, Scranton Mayor Paige Cognetti, Syracuse City Council President Helen Hudson, and Westchester County Executive George Latimer. 

As seniors begin to enroll in their 2024 Medicare plans, they could save thousands of dollars on their vaccine and prescription drug costs, with even more savings down the road. Over three weeks, Protect Our Care will travel to more than 10 states, make more than 25 stops, and travel over 7,000 miles. The tour will highlight the new cost-saving benefits for seniors on Medicare in the Inflation Reduction Act, including: 

  • Medicare negotiation for lower drug prices 
  • A $35 monthly cap on insulin 
  • Free shingles and other essential vaccinations
  • $2,000 out-of-pocket caps on prescription drugs beginning
  • Drug companies can no longer raise prices faster than the rate of inflation

For more information on why “Medicare is Better Than Ever,” read more here. 

MONDAY

SYRACUSE, NEW YORK:
WHO:
State Senator John Mannion
Syracuse Common Council President Helen Hudson
Alex Marion, Syracuse City Auditor-Elect
Bill Spreter, President of the NYS Chapter of the Alliance for Retired Americans

WHERE: Syracuse City Hall, 233 E Washington St, Syracuse, NY 13202

WHEN: Monday, October 23, 2023, at 10:00 AM ET

NEW WINDSOR, NEW YORK:
WHO:
State Senator James Skoufis

WHERE: Marasco Senior Center at the New Windsor Town Hall Complex, 555 Union Ave, New Windsor, NY 12553

WHEN: Monday, October 23, 2023, at 3:00 PM ET

TUESDAY

WESTCHESTER, NEW YORK:
WHO:
County Executive George Latimer
HHS Regional Director Dara Kass

WHERE: Theodore D. Young Community Center, 32 Manhattan Ave, White Plains, NY 10607

WHEN: Tuesday, October 24, 2023, at 11:45 AM ET

SCRANTON, PENNSYLVANIA:
WHO:
Scranton Mayor Paige Cognetti
Lori Hart, owner of Sheeley’s Drug Store
Barbara Richel, storyteller 

WHERE: Sheeley’s Drug Store, 539 Linden St, Scranton, PA 18503

WHEN: Tuesday, October 24, 2023, at 4:00 PM ET

WEDNESDAY

HARRISBURG, PENNSYLVANIA:
WHO:
Lieutenant Governor Austin Davis
Harrisburg Mayor Wanda Williams
County Commissioner George Hartwick
State Representative Patty Kim
Centers for Medicare & Medicaid Services Senior Advisor Kristi Martin

WHERE: Heinz-Menaker Senior Center, 1824 N 4th St, Harrisburg, PA 17102

WHEN: Wednesday, October 25, 2023, at 12:00 PM ET

THURSDAY

FLINT, MICHIGAN:
WHO:
HHS Regional Director Michael Cabonargi
Jim Malinowski, President & CEO of Genesee Health Plan
Alyson Ramos, Regional Coordinator of Valley Area Agency on Aging

WHERE: Brennan Senior Center, 1301 Pingree Ave, Flint, MI 48503

WHEN: Thursday, October 26, 2023, at 10:30 AM ET

LANSING, MICHIGAN:
WHO:
HHS Regional Director Michael Cabonargi
Sue Thuma, Medicare Medicaid Assistance Program Coordinator of Tri-County Office on Aging
Raj Wiener, storyteller

WHERE: Michigan State Capitol, 100 N Capitol Ave, Lansing, MI 48933

WHEN: Thursday, October 26, 2023, at 1:30 PM ET

FRIDAY

MADISON, WISCONSIN:
WHO:
HHS Regional Director Michael Cabonargi
Centers for Medicare & Medicaid Services Senior Advisor Kristi Martin
Sandy Drew, storyteller

WHERE: Goodman Community Center, 214 Waubesa St, Madison, WI 53704

WHEN: Friday, October 27, 2023, at 11:00 AM ET // 10:00 AM CT

MILWAUKEE, WISCONSIN:
WHO:
HHS Regional Director Michael Cabonargi
Centers for Medicare & Medicaid Services Senior Advisor Kristi Martin
Nancy Koch, storyteller

WHERE: Washington Park Senior Center, 4420 W Vliet Street, Milwaukee, WI 53208

WHEN: Friday, October 27, 2023, at 3:00 PM ET // 2:00 pm CT

Protect Our Care Kicks Off Multi-State “Medicare is Better Than Ever” Tour to Educate Seniors About Lower Drug Prices

Protect Our Care’s “Medicare-A-Van!” Will Travel Across 10+ States, Make Over 25 Stops and Cover Over 7,000 Miles in Four Weeks Starting October 23

Washington, D.C. — Alongside the Medicare Autumn campaign, Protect Our Care’s Medicare-A-Van is hitting the road to educate seniors across the nation about new benefits thanks to legislation signed into law last year by President Biden. As seniors begin to enroll in their 2024 Medicare plans, they could save thousands of dollars on their prescription drug costs, with even more savings down the road. The multi-state “Medicare is Better Than Ever” educational van tour will highlight all of the new cost-saving benefits for seniors in the Inflation Reduction Act, including: 

  • Medicare negotiation for lower drug prices 
  • A $35 monthly copay cap on insulin 
  • Free shingles and other essential vaccinations
  • $2,000 out-of-pocket caps on prescription drugs beginning in 2025
  • Protections from drug company price hikes thanks to increased inflationary rebates

Right now, the Biden administration is in the process of lowering prices for the first round of prescription drugs under the Medicare Drug Price Negotiation Program, and those prices will take effect in 2026. The first ten drugs selected for negotiation are taken by nearly 9 million people on Medicare, who spent $3.4 billion in out-of-pocket costs last year alone. This new program will lower prices for some of the highest-priced prescription drugs on the market used to treat conditions like diabetes, heart failure, blood clots, and autoimmune disorders. 

“As seniors go to enroll in their 2024 Medicare plans, they need to know Medicare is stronger than ever before. Thanks to the Inflation Reduction Act, people on Medicare could save thousands of dollars on their prescription drugs,” said Protect Our Care Executive Director Brad Woodhouse. All of these cost savings are a historic victory over big drug companies who fought tirelessly to protect their sky-high profits while charging seniors up to four times more for their prescriptions than people in other countries. Now seniors can have some peace of mind knowing Big Pharma’s broken system is finally coming to an end.” 

Protect Our Care’s Medicare-A-Van will make stops in: 

Syracuse, New York on Monday, October 23, 2023
New Windsor, New York on Monday, October 23, 2023
Westchester, New York on Tuesday, October 24, 2023
Scranton, Pennsylvania on Tuesday, October 24, 2023
Harrisburg, Pennsylvania on Wednesday, October 25, 2023
Flint, Michigan on Thursday, October 26, 2023
Lansing, Michigan on Thursday, October 26, 2023
Madison, Wisconsin on Friday, October 27, 2023
Milwaukee, Wisconsin on Friday, October 27, 2023
Harrisonburg, Virginia on Monday, October 30, 2023
Roanoke, Virginia on Tuesday, October 31, 2023
Raleigh, North Carolina on Wednesday, November 1, 2023
Greensboro, North Carolina on Wednesday, November 1, 2023
Atlanta, Georgia on Thursday, November 2, 2023
Macon, Georgia on Friday, November 3, 2023
Phoenix, Arizona on Monday, November 6, 2023
Tucson, Arizona on Monday, November 6, 2023
Las Vegas, Nevada on Tuesday, November 7, 2023
Reno, Nevada on Wednesday, November 8, 2023
Sacramento, California on Wednesday, November 8, 2023
Los Angeles, California on Thursday, November 9, 2023
San Diego, California on Thursday, November 9, 2023